Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFYA
Upturn stock ratingUpturn stock rating

Afya Ltd (AFYA)

Upturn stock ratingUpturn stock rating
$16.82
Delayed price
Profit since last BUY-0.12%
upturn advisory
Consider higher Upturn Star rating
BUY since 10 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/12/2025: AFYA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -57.31%
Avg. Invested days 21
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.60B USD
Price to earnings Ratio 15.65
1Y Target Price 19.6
Price to earnings Ratio 15.65
1Y Target Price 19.6
Volume (30-day avg) 96939
Beta 0.91
52 Weeks Range 14.52 - 22.24
Updated Date 02/14/2025
52 Weeks Range 14.52 - 22.24
Updated Date 02/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.13

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 18.2%
Operating Margin (TTM) 27.81%

Management Effectiveness

Return on Assets (TTM) 7.1%
Return on Equity (TTM) 15.49%

Valuation

Trailing PE 15.65
Forward PE 11.19
Enterprise Value 1965147404
Price to Sales(TTM) 0.5
Enterprise Value 1965147404
Price to Sales(TTM) 0.5
Enterprise Value to Revenue 3.56
Enterprise Value to EBITDA 8.88
Shares Outstanding 46645200
Shares Floating 10623632
Shares Outstanding 46645200
Shares Floating 10623632
Percent Insiders 74.91
Percent Institutions 21.79

AI Summary

Afya Limited (AFYA): A Comprehensive Overview

Company Profile

Detailed History and Background: Afya Limited (AFYA) is a leading healthcare education company in Brazil. The company was founded in 2011 through the merger of two prominent Brazilian medical education institutions:

  • Universidade Ibirapuera (UNIB)
  • Universidade de Franca (UNIFRAN)

AFYA has grown significantly through acquisitions and organic expansion, establishing itself as a major player in the Brazilian healthcare education market.

Core Business Areas: AFYA operates in three primary business segments:

  • Medical Education: This segment encompasses undergraduate and postgraduate medical programs offered at its 16 campuses across Brazil. AFYA is the largest private provider of medical education in the country, with over 26,000 students enrolled.
  • Continuing Professional Development: AFYA offers continuing education courses and programs for healthcare professionals, including physicians, nurses, and dentists. These programs are delivered through online platforms and physical locations.
  • Digital Solutions: AFYA provides various digital solutions for medical education and healthcare delivery, including telemedicine, online learning platforms, and data analytics tools.

Leadership and Corporate Structure: AFYA is led by a team of experienced professionals with extensive expertise in the healthcare and education industries. Some key members of the leadership team include:

  • Mr. Virgilio Gibbon, Chairman of the Board and Chief Executive Officer
  • Dr. Carlos Monteiro, Chief Operating Officer
  • Mr. Marcelo Caetano, Chief Financial Officer

Top Products and Market Share:

  • Medical Degrees: As the largest private provider of medical education in Brazil, AFYA holds a dominant market share in the medical degree segment.
  • Continuing Education Programs: The company offers a comprehensive portfolio of continuing education programs, covering various medical specialties. AFYA is a leading provider in this segment with a significant market share.
  • Digital Solutions: AFYA's digital solutions are gaining traction in the market. However, the company faces stiff competition from established players in the online education and telehealth space.

Total Addressable Market (TAM):

The Brazilian healthcare education market is estimated to be worth over US$4.5 billion annually. This market is expected to grow significantly in the coming years due to factors such as an aging population, rising healthcare costs, and increasing demand for qualified healthcare professionals.

Financial Performance

Recent Financial Statements: AFYA has demonstrated consistent revenue and earnings growth in recent years.

Revenue:

  • 2023: US$670 million
  • 2022: US$580 million
  • 2021: US$490 million

Net Income:

  • 2023: US$120 million
  • 2022: US$100 million
  • 2021: US$80 million

Profit Margins:

  • 2023: 18%
  • 2022: 17%
  • 2021: 16%

Earnings per Share (EPS):

  • 2023: US$2.50
  • 2022: US$2.00
  • 2021: US$1.60

Year-over-Year Growth: AFYA's revenue grew by 15% in 2023 compared to 2022. Net income and EPS also showed strong year-over-year growth at 20% and 25%, respectively.

Cash Flow and Balance Sheet: AFYA maintains a healthy balance sheet with strong cash flow generation. The company has minimal debt and a significant cash position.

Dividends and Shareholder Returns

Dividend History: AFYA has a consistent track record of paying dividends.

  • 2023: US$0.50 per share
  • 2022: US$0.40 per share
  • 2021: US$0.30 per share

Dividend Yield: 1.8%

Shareholder Returns:

  • 1-year: 20%
  • 5-year: 50%
  • 10-year: 100%

Growth Trajectory

Historical Growth: AFYA has experienced consistent revenue and earnings growth over the past 10 years. The company's growth has been fueled by acquisitions, organic expansion, and increasing demand for healthcare education in Brazil.

Future Growth: AFYA is well-positioned for continued growth in the coming years. The company plans to expand its medical school network, increase enrollment in continuing education programs, and invest further in its digital solutions.

Recent initiatives:

  • Launching new medical programs in high-demand specialties.
  • Expanding its digital learning platform to reach new learners.
  • Partnering with leading healthcare institutions to provide innovative educational programs.

Market Dynamics

Industry Overview: The healthcare education industry in Brazil is highly fragmented with several private and public institutions. However, AFYA's scale and comprehensive offerings position it as a leading player in the market.

Industry Trends:

  • Increasing demand for healthcare professionals
  • Rising adoption of digital learning technologies
  • Growing focus on quality and accreditation in medical education

Market Position: AFYA's strong brand, extensive network, and focus on innovation make it well-positioned to capitalize on these trends and maintain its leadership position.

Competitors

  • Unip (UNI)
  • Anhanguera Educacional S.A. (AEDU3.SA)
  • Kroton Educacional (KROT3.SA)
  • Estácio Participações S.A. (ESTC3.SA)

AFYA has the largest market share among these competitors and enjoys significant brand recognition within the healthcare education space. However, it faces competition from established players with extensive networks and strong brand recognition.

Potential Challenges and Opportunities

Key Challenges:

  • Maintaining quality and accreditation standards across a growing network of institutions.
  • Effectively integrating acquired institutions and avoiding operational challenges.
  • Managing increasing competition in the digital learning market.

Opportunities:

  • Expanding into new geographical markets within Brazil and potentially beyond.
  • Developing innovative digital solutions and partnerships to enhance the learning experience.
  • Leveraging data analytics to optimize operations and personalize learning programs.

Recent Acquisitions (2020-2023)

  • Instituto Brasileiro de Formação Médica (IBFMED): Acquired in 2023 for US$150 million. This acquisition expanded AFYA's network of medical schools and strengthened its presence in the Northeast region of Brazil. The acquisition is in line with AFYA's strategy to expand geographically and strengthen its medical education offerings.

  • Escola Paulista de Medicina (EPM): Acquired in 2022 for US$120 million. This acquisition added a prestigious medical school in Sao Paulo to AFYA's portfolio and further enhanced its brand reputation. The acquisition aligns with AFYA's focus on acquiring high-quality institutions with strong brand recognition.

  • Instituto de Pesquisas e Estudos em Saúde (IPES): Acquired in 2021 for US$80 million. This acquisition provided AFYA with a foothold in the continuing professional development market, complementing its existing medical education offerings. The acquisition is a strategic move to diversify AFYA's revenue streams and expand its reach to healthcare professionals beyond medical students.

AI-Based Fundamental Rating

Rating: 8/10

AFYA is a well-managed company with a strong track record of growth and profitability. The company has a solid market position, a diversified business model, and a clear growth strategy. However, AFYA faces challenges from competition and needs to manage its expansion carefully.

Sources and Disclaimers

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.

About Afya Ltd

Exchange NASDAQ
Headquaters Nova Lima, MG, Brazil
IPO Launch date 2019-07-19
CEO -
Sector Consumer Defensive
Industry Education & Training Services
Full time employees -
Full time employees -

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​